By Mark DaCosta- January has been designated as Cervical Cancer Awareness Month, underscoring the urgent need for heightened attention towards this critical public health issue that predominantly affects women in our country. Cervical cancer stands as the second most common form of cancer among females and is a major contributor to cancer-related deaths. As we navigate through this month, it is crucial to understand the local implications of this disease — from its causes and risk factors to the community’s response through government initiatives and health policies.
Cervical cancer arises from the abnormal proliferation of cells in the cervix, which connects the uterus to the vagina. In its nascent stages, the disease often presents without any noticeable symptoms, making regular screening an essential preventive strategy. If left unchecked, these abnormal cells could penetrate deeper tissues, subsequently leading to the spread of cancer to other body parts. This reality emphasises the importance of early detection and consistent health monitoring.
The predominant cause of cervical cancer is persistent infection with specific high-risk strains of the Human Papillomavirus (HPV). This sexually transmitted infection is alarmingly prevalent, particularly among young women aged 20 to 30 in our society. Notably, strains 16 and 18 are responsible for roughly 70 percent of global cervical cancer cases. In our nation, Indigenous Amerindian and Afro-Guyanese women find themselves at a higher risk, due to several factors, including early sexual initiation, elevated birth rates, and historically inadequate access to rural healthcare services.
Socioeconomic conditions also play a significant role in determining one’s susceptibility to this disease. Women from lower-income backgrounds often face challenges associated with poor nutrition and limited access to healthcare. The prevalence of HIV, particularly among women aged 15 to 49 years where the infection rate stands at 1.4 percent, further complicates the situation by diminishing immune responses to HPV. These various factors collectively underscore a pressing public health crisis that demands immediate action from both the government and health agencies.
Treatment pathways for cervical cancer in our nation significantly vary based on the diagnosed stage of the illness. As local healthcare services continue to evolve, the Georgetown Public Hospital Corporation (GPHC) and the Cancer Institute of Guyana are leading the charge in modernising oncology care. Women diagnosed at an early stage may undergo surgical interventions such as hysterectomies or cone biopsies to remove cancerous tissue. In contrast, those facing advanced stages of the disease typically require a combination of chemotherapy and radiation therapy. Encouragingly, recent governmental collaborations, such as the initiative with Mount Sinai to establish a national cancer centre, have been announced, promising to enhance available oncology services substantially.
In a bid to address the alarming rates of cervical cancer, our country is shifting towards a robust prevention model. Historically, screening rates have been dismally low, with only one in ten women undergoing necessary examinations. To combat this challenge, a comprehensive strategy has been launched that includes extensive HPV vaccination campaigns. In 2025, our nation became the pioneering Caribbean country to introduce the HPV-9 vaccine, affording protection against nine strains of the virus. This vaccine is now accessible to girls aged 9-15 and women up to 45 at no cost, with a phased approach to ensure maximum outreach.
In tandem with vaccination efforts, the Ministry of Health has initiated an $8,000 GYD voucher programme targeting women aged 21 to 65. This initiative aims to remove financial impediments by providing women with vouchers for essential HPV testing and Pap smears at approved facilities. The overarching goal is to elevate screening to 40 percent of the female population in the near term and to screen 200,000 women by 2030. Such ambitious targets reflect a growing recognition of the need for preventative measures in the fight against cervical cancer.
The success of these initiatives hinges significantly on early detection. When cervical cancer is identified at the pre-cancerous stage, the survival rate can soar to nearly 100 percent with minimal intervention. Regrettably, many women in our nation are still diagnosed at stages where treatment is considerably less effective, leading to an estimated 63 deaths annually out of 121 new cases — a staggering 50 percent mortality rate. The movement towards achieving 90 percent vaccination coverage and expanding screening capabilities by 2030 underscores a determination to transform cervical cancer from a prevalent killer into a largely preventable disease.
As we observe Cervical Cancer Awareness Month, it becomes evident that the fight against this disease cannot rest solely on the shoulders of healthcare providers. It requires a concerted effort across every segment of our society — government, healthcare institutions, and communities alike — to raise awareness, promote preventive measures, and ensure that every woman in our country has the resources needed to protect her health.
In this context, it is vital to scrutinise the roles and responsibilities of our political leaders in addressing this health issue effectively. While the government has initiated various promising programmes, there is a pressing need for sustained commitment to enhance healthcare access and reach vulnerable populations. An honest appraisal of past failures in public health infrastructure must also be part of our ongoing dialogue. Only through collective action and accountability can we hope to combat the cervical cancer crisis effectively and improve the health outcomes for all women.
